The hypolipidemic eŠect of an exo-biopolymer produced from a submerged mycelial culture of Hericium erinaceus was investigated in dietary-induced hyperlipidemic rats. Hypolipidemic eŠects were proportionally increased with the increasing concentration of the exo-biopolymer for oral administration. The exobiopolymer, at the dose of 200 mg W kg body weight, substantially reduced the plasma total cholesterol (32.9%), LDL cholesterol (45.4%), triglyceride (34.3%), phospholipid (18.9%), atherogenic index (58.7%), and hepatic HMG-CoA reductase activity (20.2%). It increased the plasma HDL cholesterol level (31.1%) as compared to the control group. The molecular mass of this exo-biopolymer measured by HPLC was under 40 kDa. Total sugar and protein contents were 91.2 and 8.8%, respectively. The sugar and amino acid compositions of the exo-biopolymer were analyzed in detail.
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Key words: exo-biopolymer; HMG-CoA reductase; hypolipidemic eŠect; Hericium erinaceus; submerged mycelial culture Edible mushrooms were well known for the ideal materials for the dietetic prevention of atherosclerosis due to their high content ofˆber, proteins, and microelements, and their low fat content. 1, 2) The hypocholesterolemic eŠect of a few mushrooms have already been studied. It has been reported that Auricularia auricula-judae, 3) Polyporus con‰uens, 4) and Ganoderma lucidum 5) lower the serum cholesterol concentration in hyperlipidemic rats. However, the earlier reports on hypolipidemic eŠect of mushrooms were mostly restricted to the compounds extracted either from the fruiting bodies or the mycelia. Very little eŠort was made to explore the hypolipidemic potential of the compounds liberated from the cultured mycelia into the culture media, which, however, are reported to have various bioactive properties. 6) Bioactive extracellular polysaccharides produced from a submerged mycelial culture of mushrooms has also recently been studied, because the production process from a culture broth requires only relatively simple puriˆcation steps. 7) Hericium erinaceus is a well known edible and medicinal mushroom in oriental countries. This mushroom is called``yamabushitake'' and``houtou'' in Japan and China, respectively. It has been demonstrated that H. erinaceus contains many biologically active compounds, which have shown interesting biological activities such as promotion of the synthesis of neuro-growth factor, 8) cytotoxic eŠect, 9) antimicrobial eŠect, 10) and anti-tumor activities.
11)
In this study, a dose-dependent hypolipidemic eŠect of EBP produced from a submerged mycelial culture of H. erinaceus was investigated by oral administration to hyperlipidemic rats. Chemical compositions and the molecular mass of EBP were also measured.
Materials and Methods
Strain and production of EBP. The culture of H. erinaceus was obtained from the Rural Development Administration in Korea. The H. erinaceus was maintained on a potato W dextrose agar (PDA, Difco) slant at 49 C and subcultured every 3 months. The seed culture of H. erinaceus was grown in a 250-ml ‰ask containing 100 ml of a potato W dextrose broth (pH 5.0) on a rotary shaker (120 rpm) at 259 C. After 10 days, 50 ml of the culture broth was aseptically homogenized and inoculated at 1z(v W v) into a culture medium with the following composition (g W l): glucose, 20; MgSO4･7H2O, 0.5; KH2PO4, 0.46; K2HPO4, 1.0; yeast extract, 2; peptone, 2; the pH was adjusted to 4 before sterilization. The submerged mycelial culture was done in 500-ml ‰asks, each containing 200 ml of the medium, on a rotary shaker (120 rpm) at 259 C for 12 d. Culture broth was harvested by centrifugation (10,447×g W 20 min) and the supernatant was treated with ethanol. The ethanol precipitate was dissolved in water, dialyzed, and lyophilized to obtain an EBP. 12) Animal experiments. Sprague-Dawley male rats (4 weeks of age) obtained from the Korea Research Institute of Chemical Technology were housed individually in stainless steel cages in a room with controlled temperature (22±29 C) and humidity (55 ±5z), and a 12-h cycle of light and dark. The rats were fed with a modiˆed AIN-76 13) diet for 6 weeks. The diets consisted of 55.5z carbohydrates, 14z fats (30z of total energy), 20z protein, 5zˆber, and 0.5z cholesterol by weight. The animals were provided with the diets and water ad libitum. Two weeks after adapting them in the growth room, they were brought into the experimental conditions. In the main experiment, the rats of each group were administered (between 08.00 and 09.00 hr) with saline (control) and EBP at the levels of 50-200 mg W kg BW, using an oral zonde daily for 4 weeks.
The food intake and body weights were respectively recorded every other day and every day. At the end of this oral administration, the animals were starved for 14 h and then immediately killed (between 08.00 and 10.00 hr) following an abdominal incision under light ether anesthesia, before blood was collected from the main artery. Blood samples were collected in heparinized tubes, and the plasma was separated by centrifugation at 1,100×g for 10 min. Livers were perfused with cold saline, excised, and kept frozen at -709 C. Total lipids from the liver were extracted by treatment with a chloroform W methanol (2:1, v W v) mixture. 14) Chemical analysis. The plasma TC, TG, HDL cholesterol, and PL levels were evaluated by enzymatic test kits (Asan Pharm. Co., Korea). LDL cholesterol 15) and atherogenic index were calculated by the following equation: LDL cholesterol＝TC-HDL cholesterol-(TG W 5), atherogenic index＝(TC -HDL cholesterol) W HDL cholesterol. Liver TC and TG were assayed using the same method as for the plasma TC and TG after the treatment with Triton X-100.
Isolation of microsomal protein. The liver microsomes were prepared by the method developed by Hulcher and Oleson 16) with a slight modiˆcation. One gram of liver tissue was homogenized in 3 ml of cold homogenization buŠer (pH 7.2) containing 50 mM KH2PO4, 0.1 M sucrose, 50 mM KCl, 50 mM NaCl, 30 mM EDTA, and 2 mM dithiothreitol, using a homogenizer (Glas-Col. Co., U.S.A.). A microsomal fraction was isolated by two 15-min centrifugations at 10,000×g followed by a 1-h centrifugation at 100,000×g in a Ti-50 rotor at 49 C. Microsomes were resuspended in homogenization buŠer and centrifuged for an additional hour at 100,000×g. After centrifugation, microsomal pellets were homogenized with homogenization buŠer without dithiothreitol and stored at -709 C. The protein was measured by the method of Lowry.
17)
Assay of HMG-CoA reductase activity. The HMG-Co A reductase activities were measured using freshly prepared hepatic microsomes, as described by Shapiro et al. 18) with a slight modiˆcation. The incubation mixtures (60 ml) containing microsomes (200 mg) and 500 nM NADPH (dissolved in a reaction buŠer containing 0.1 M triethanolamine and 10 mM EDTA) were incubated at 379 C for 15 min. Then, 50 nM [
14 C] HMG-CoA (NEN Life Science Products, Inc., U.S.A.) was added and incubated at 379 C for 15 min. The reaction was stopped by the addition of 15 ml of 10 M HCl and the resulting reaction mixture was further incubated at 379 C for 30 min to turn the mevalonate into mevalonolactone. The incubation mixture was centrifuged at 10,000×g for 15 min and the supernantant was spotted on a silica gel 60F 254 TLC plate (Merck Co., Germany) with a mevalonolactone standard. The plate was developed in acetone:benzene (1:1, v W v), and air-dried. The area containing mevalonate was removed by scraping with a clean razor blade and its [
14 C] radioactivity was measured using a scintillation counter (Packard Tricarb 1600 TR, Packard Co., Netherlands). The results were expressed as pmoles of mevalonate formed per min per mg of microsomal protein.
Statistical analysis. Each data value is expressed as the mean±SE. Group means were compared by a one-way analysis of variance and Duncan's multiplerange test. 19) Statistical diŠerences were considered signiˆcant at pº0.05.
Gelˆltration and measurement of molecular weight. EBP obtained from culture broth was dissolved in 0.2 M NaCl andˆltered on a gel column (2.6 ×99 cm) of Sepharose CL-6B equilibrated with 0.2 M NaCl at a ‰ow rate of 5 ml W tube volume. The molecular weight of EBP was measured by HPLC using the Shodex GS520＋GS320＋GS220 packed column. Standard pullulans (P1600, 800, 400, 200, 100, 50, 20, 10, and 5) were used for the measurement of molecular weight as the standard.
Analysis of component sugars and amino acids.
The total sugar content of EBP was measured by the phenol-sulfuric acid method, 20) using a mannose and galactose mixture (1:1) as the standard. The sugar composition was analyzed by a GC 3600 gas chromatograph (Varian Co.) based on the hydrolysis and acetylation method described by Jones and Alber- sheim. 21) The total protein content of EBP was measured by the method of Lowry, 17) with bovine serum albumin used as the standard. The amino acid composition was analyzed by a Biochrom 20 amino acid auto-analyzer (Pharmacia Biotech.) with an Na-form column after hydrolysis of the protein.
22)

Results and Discussion
Growth response
The EBP produced by a submerged mycelial culture of H. erinaceus was used in the dose-dependent study for conˆrmation of its hypolipidemic eŠect. During the 4-week period, the rats from all experimental groups were healthy and demonstrated normal BW gain. In the four experimental groups, the BW gain and food intake were not signiˆcantly diŠerent from the control group (Table 1) . Moreover, the oral administration of the EBP caused no changes in gross behavior and none of the animals died. Thus, there was no harmful eŠects in the rats following oral administration of the H. erinaceus EBP.
Hypolipidemic eŠect
The eŠects of H. erinaceus EBP on the plasma TC and LDL cholesterol in the hyperlipidemic rats are shown in Table 2 . The TC and LDL cholesterol levels in plasma were signiˆcantly reduced in all experimental groups, and dropped further with increasing doses. In the light of current knowledge, the strongest relationship was found between the plasma LDL cholesterol and atherosclerosis rather than the TC. 23) In this study, the EBP, at a dose of 200 mg W kg BW, lowered the plasma TC and LDL cholesterol levels by as much as 32.9 and 45.4z, respectively, as compared to the control group. The hypolipidemic eŠect exerted by the EBP of H. erinaceus may result from the viscous nature of the EBP.
24) The hypolipidemic eŠect was steadily increased with the increasing concentration of EBP. This is consistent with the increased viscosity with the increasing dose of the EBP. Perhaps for this property it could lower the TG and cholesterol absorption by inhibiting the formation of micelles in the small intestine and by altering the physical characteristics of the intestinal mucosa of rats. 25) Cheung 6) also propounded similar fact while studying the hypocholesterolemic eŠects of Volvariella volvacea exo-polysaccharides. However, Evans et al. 26) have suggested that hypocholesterolemic eŠect of galactomannan was not governed by its viscous nature but by the composition and the structure itself. Therefore, the possibility of any structural in‰uence of the H. erinaceus EBP in having a hypolipidemic eŠect cannot be excluded. Moreover, like TC, the LDL cholesterol level was steadily decreased with the increasing daily dose of the EBP. So it can be stated that the main reason for the reduction of plasma TC level was due to the ability of the EBP to lower the LDL cholesterol levels. A substantial reduction of LDL and TC in plasma may also be due to a reduced production of cholesterol by the liver tissue (by inhibiting HMG Co-A reductase) and W or e‹cient removal of the LDL cholesterol by various tissues without subsequent renewal. Plasma LDL values are aŠected by modiˆ-cations in VLDL metabolism, including the rate of conversion of VLDL to LDL. Basically, nascent VLDL is converted to mature VLDL and to LDL through the loss of TG by action of LPL. Shen et al. 27) have suggested that the LDL cholesterol-lowering eŠect of Psyllium was due to slow conversion of VLDL to LDL. Table 3 shows the eŠects of the H. erinaceus EBP on the plasma HDL cholesterol and atherogenic index. As compared to the control group, the EBP, at the dose of 200 mg W kg BW, increased the plasma HDL cholesterol level by as much as 31.1z and decreased the atherogenic index by as much as 58.7z. The plasma HDL cholesterol, an indicator of anti-atherosclerosis, is involved in the transport of excess cholesterol to the liver for reprocessing. It has been reported that some dietaryˆbers elevated HDL cholesterol level in plasma, 28) and Kim et al. 3) have reported that the fruiting body of L. edodes increased plasma HDL cholesterol level in rats. As discussed earlier, the increased HDL value in this investigation may be due to the lower conversion of HDL to LDL or by some other means. In addition, the EBP, at the dose of 200 mg W kg BW, also reduced the plasma TG and PL levels by as much as 34.3 and 18.9z, respectively, as compared to those of the control group (Table 4) . Kinnunen et al. 29) have demonstrated that the TG lowering eŠect in plasma was due to the elevated LPL activity and Sugiyama et al. 30) have demonstrated that eritadenine showed the hypocholesterolemic activity by modifying the PL metabolism in rats.
The liver TC levels in the EBP-administered groups were not signiˆcantly diŠerent from the control group but their levels tend to be reduced in experimental groups. And the EBP, at the dose of 200 mg W kg BW, reduced the TG levels in liver by 33.8z as compared to that of the control group (Table 5) . It has been demonstrated that the hepatic cholesterol concentration is related to the activities of hepatic enzymes of cholesterol synthesis and esteriˆ-cation, and the expression of apo B W E receptors, which are the major determinants of plasma LDL concentrations. Cholesterol accumulation in the liver can result in increased esteriˆcation and storage, increased secretion of cholesterol in hepatic lipoproteins and decreased uptake of plasma cholesterol via the LDL receptor. 31) Hepatic HMG-CoA reductase activity were signiˆcantly reduced by oral administration of the EBP at the dose of 50, 100, 150, and 200 mg W kg BW by 2.5, 13.6, 15.7, and 20.2z, respectively, as compared to that of the control group (Table 6) . Their levels were steadily decreased with the increase in daily dose, which can be positively correlated with the plasma TC level in experimental groups. Their correlation coe‹cient (r ) appeared to be 0.886 at pº0.05. Evans et al. 26) have reported that galactomannans showed substantial reductions in the rate of hepatic synthesis of cholesterol, and, moreover, the magnitude of the reduction was proportional to the lowering of plasma cholesterol. Cheung 6) has demonstrated that the exo-polysaccharide of V. volvacea reduced the activity of the HMG-CoA reductase. It has been reported that Pleurotus sp contained lovastatin, an inhibitor of HMG-CoA reductase enzyme. 32) Lovastatin, also called mevinolin, is used as a hypocholesteremic agent. 33) These results suggested that one of the main reasons for the cholesterollowering eŠect of H. erinaceus EBP was the reduc- The volume of each fraction was 5 ml, and the eluates were checked by measuring the absorbance at 490 nm after a phenolsulfuric acid reaction for sugar, and at 280 nm after a Lowry reaction for protein. Fig. 2 . Measurement of the Molecular Weight of the Hericium erinaceus Exo-biopolymer by Using HPLC. P-400, molecular weight 400,000 of pullulan; P-200, molecular weight 200,000 of pullulan; P100, molecular weight 100,000 of pullulan; P-50, molecular weight 50,000 of pullulan; P-20, molecular weight 20,000 of pullulan; P-10, molecular weight 10,000 of pullulan; P-5, molecular weight 5,000 of pullulan; glucose, molecular weight 180. Kav＝(Ve-Vo) W (Vt-Vo) (Vo: Void volume, Vt: Total volume, Ve: Elution volume). tion of cholesterol synthesis by inhibiting hepatic HMG-CoA reductase activity in dietary-induced hyperlipidemic rats. Therefore, it is considered that the reduction of HMG-CoA reductase activity is one of the major reasons for lowering plasma TC level of the EBP of H. erinaceus.
Chemical analysis of EBP EBP produced from the submerged mycelial culture of H. erinaceus yielded only a single peak when put through Sepharose CL-6B column chromatography (Fig. 1) , and the molecular mass of the EBP was estimated to be about 40 kDa by HPLC (Fig. 2) .
Total sugar and protein contents of this EBP were found to contain 91.2z, and 8.8z, respectively. A detailed chemical analysis of EBP is summarized in Table 7 . Seventeen diŠerent kinds of amino acid constituted the protein moiety, of which the major amino acids were appeared to be aspartic acid (10.5z), serine (16.6z), glutamic acid (10.5z), and glycine (10.0z). Fucose (20.1z), mannose (35.4z), and galactose (34.1z) appeared to be the major carbohydrates of the sugar moiety. Earlier studies with polymer extracted from H. erinaceus fruiting bodies and mycelia have demonstrated various other bioactive properties, although the chemical composition of those glycoproteins diŠered from our presentˆnd-ings. Kawagishi et al. 8) have reported a nerve growth factor of H. erinaceus and characterized it as``sialic acid-binding lectin''. Mizuno et al. 11) and Kim et al. 10) have demonstrated the antitumor activity and antimicrobial properties of H. erinaceus, suggested the chemical nature as a``glucoxylan-protein complex''. The diŠerence in the chemical properties of polymer of H. erinaceus in diŠerent investigators may have been due to the diŠerent extraction or culture methods. On the other hand, the report on hypolipidemic exo-polymers from submerged mycelial culture of mushrooms came from the work of Yang et al. 34) who conˆrmed that the hypolipidemic EBP from Auricularia polytricha was a branched galactomannan composed of galactose and mannose in the compostion of 51.2 and 32.9z, respectively. Cheung 6) has suggested that the b-glucan was the main factor for the hypocholesterolemic activity of mycelial extracellular polysaccharide produced from submerged culture of V. volvacea. In this study, the content of mannose and galactose within total sugar of H. erinaceus EBP occupied almost 70z. It is considered that the EBP of H. erinaceus is close to a galactomannan, and, moreover, contains similar amounts of galactose and mannose. Meanwhile, the hypolipidemic eŠect of galactomannans has already been proved by many investigators. 26, 35) In particular, Evans et al. 26) have reported that diŠerent molar ratios of galactose to mannose aŠected the hypocholesterolemic eŠect of galatomannan in rats and the most eŠect appeared in the fenugreek gum group, which contain the highest proportion of galactose in the galactomannan. Therefore, it is considered that the hypolipidemic eŠect of H. erinaceus EBP was in‰uenced by chemical composition and the structure itself.
This investigation demonstrated the potential of H. erinaceus EBP in reducing the level of cholesterol rich-LDL (which are quantitatively the most signiˆcant lipoprotein class in the control of serum cholesterol levels) and preserving the HDL at relatively high level. All of these eŠects would help to reduce the risk of atherosclerosis. Although it is proved that one of the major reasons for the hypocholesterolemic eŠect of the H. erinaceus EBP appeared to be due to the reduced cholesterol synthesis in the liver, the exact mechanism of the H. erinaceus EBP in causing this hypocholesterolemic eŠect was not clear to us. Also, it cannot be ruled out the possibility of combined eŠects of the EBP in exerting hypocholesterolemia. The combined eŠects involved were 1) the inhibition of cholesterol absorption and 2) the inhibition of biosynthesis of LDL and acceleration of their fractional turnover. However, further comprehensive chemical and pharmacological investigations are needed to discover the exact mechanism of hypolipidemic eŠects and to isolate the active principles of these mushrooms before they can be useful for preventive and therapeutic purposes to alleviate the hyperlipidemic status.
